Summary
Latest filing:
DSS, INC. is 10% Owner of IMPACT BIOMEDICAL INC. (IBO). 2 SEC Form 4 filings on record going back to 2024, most recently on 6 January 2026. Most recent open-market trade: sold $25K of IBO on 6 January 2026. Lifetime open-market sales: $105K.
Recent Transactions
5Every recent SEC Form 4 transaction DSS, INC. has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies DSS, INC. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jason Grady - $33K of IBO open-market activity in the last 12 months
- Todd D. Macko - $25K of IBO open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is DSS, INC.?
DSS, INC. is a corporate entity, tracked as 10% Owner of IMPACT BIOMEDICAL INC. (IBO). InsiderAlpha holds 2 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did DSS, INC. last file a Form 4?
The most recent primary Form 4 on record is dated 6 January 2026, one of 2 filings going back to 2024.
Has DSS, INC. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($105K) across all tracked filings.
Where can I see all of DSS, INC.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow DSS, INC. and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
